Synapse - Olivia Heffernan

Olivia Heffernan

Research Focus

Medicine; Clinical Research Supervisor

Recent additions – View all

Treatment response and clinical outcomes of neuroendocrine neoplasms (NENs) treated with immune checkpoint inhibitors (ICIs): A single institution experience
Meeting Abstract

Hauser, H.; Le, T.; Chou, J. F.; Heffernan, O.; DeMore, A.; Gonen, S.; Capanu, M.; Reidy-Lagunes, D.; Raj, N.
Pancreas (2022)

Fulltext@MSK | Save
Randomized blinded study comparing injection site pain from octreotide long-acting-release (LAR) versus lanreotide during the treatment of well- differentiated neuroendocrine tumors (WDNETs)
Meeting Abstract

Raj, N.; Cruz, E.; Chou, J.; Capanu, M.; DeMore, A.; Hauser, H.; Heffernan, O.; Le, T.; Saltz, L.; Reidy-Lagunes, D.
Pancreas (2022)

Fulltext@MSK | Save
A randomized trial evaluating patient experience and preference between octreotide long-acting release and lanreotide for treatment of well-differentiated neuroendocrine tumors
Journal Article

Raj, N.; Cruz, E.; O'Shaughnessy, S.; Calderon, C.; Chou, J. F.; Capanu, M.; Heffernan, O.; DeMore, A.; Punn, S.; Le, T.; more...
JCO Oncology Practice (2022)

Fulltext@MSK | Save

Co-authors at MSK

6

Capanu
6

Chou
5

Hauser
5

Le
5

Raj
5

Reidy
4

DeMore
3

Cruz
3

Saltz
1

Abou-Alfa
1

Calderon
1

Do
1

El Dika
1

Erinjeri
1

Ferrer
1

Harding
1

Jarnagin
1

Khalil
1

Merghoub
1

O'Shaug...
1

Punn
1

Yarmoha...

Types of Work

Publications